-
1
-
-
0037260139
-
Cancer statistics, 2003
-
Jemal AT, Murray A, Samuels A, Ghafoor E, Ward, Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 53(1): 5-26, 2003
-
(2003)
CA Cancer J Clin
, vol.53
, Issue.1
, pp. 5-26
-
-
Jemal, A.T.1
Murray, A.2
Samuels, A.3
Ghafoor, E.4
Ward5
Thun, M.J.6
-
2
-
-
0025998557
-
Aspirin use and reduced risk of fatal colon cancer
-
Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325(23): 1593-1596, 1991
-
(1991)
N Engl J Med
, vol.325
, Issue.23
, pp. 1593-1596
-
-
Thun, M.J.1
Namboodiri, M.M.2
Heath Jr., C.W.3
-
3
-
-
0028556801
-
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
-
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC: Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121(4): 241-246, 1994
-
(1994)
Ann Intern Med
, vol.121
, Issue.4
, pp. 241-246
-
-
Giovannucci, E.1
Rimm, E.B.2
Stampfer, M.J.3
Colditz, G.A.4
Ascherio, A.5
Willett, W.C.6
-
4
-
-
0029150934
-
Aspirin and the risk of colorectal cancer in women
-
Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE: Aspirin and the risk of colorectal cancer in women. N Engl J Med 333(10): 609-614, 1995
-
(1995)
N Engl J Med
, vol.333
, Issue.10
, pp. 609-614
-
-
Giovannucci, E.1
Egan, K.M.2
Hunter, D.J.3
Stampfer, M.J.4
Colditz, G.A.5
Willett, W.C.6
Speizer, F.E.7
-
5
-
-
0027993458
-
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
-
Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107(4): 1183-1188, 1994
-
(1994)
Gastroenterology
, vol.107
, Issue.4
, pp. 1183-1188
-
-
Eberhart, C.E.1
Coffey, R.J.2
Radhika, A.3
Giardiello, F.M.4
Ferrenbach, S.5
DuBois, R.N.6
-
6
-
-
0029913633
-
Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors
-
DuBois RN, Radhika A, Reddy BS, Entingh AJ: Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110(4): 1259-1262, 1996
-
(1996)
Gastroenterology
, vol.110
, Issue.4
, pp. 1259-1262
-
-
DuBois, R.N.1
Radhika, A.2
Reddy, B.S.3
Entingh, A.J.4
-
7
-
-
0029839213
-
Elevated cyclooxygenase-2 levels in Min mouse adenomas
-
Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD, DuBois RN: Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111(4): 1134-1140, 1996
-
(1996)
Gastroenterology
, vol.111
, Issue.4
, pp. 1134-1140
-
-
Williams, C.S.1
Luongo, C.2
Radhika, A.3
Zhang, T.4
Lamps, L.W.5
Nanney, L.B.6
Beauchamp, R.D.7
DuBois, R.N.8
-
8
-
-
0030606299
-
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
-
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM: Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87(5): 803-809, 1996
-
(1996)
Cell
, vol.87
, Issue.5
, pp. 803-809
-
-
Oshima, M.1
Dinchuk, J.E.2
Kargman, S.L.3
Oshima, H.4
Hancock, B.5
Kwong, E.6
Trzaskos, J.M.7
Evans, J.F.8
Taketo, M.M.9
-
9
-
-
0032006784
-
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
-
Kawamori T, Rao CV, Seibert K, Reddy BS: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58(3): 409-412, 1998
-
(1998)
Cancer Res
, vol.58
, Issue.3
, pp. 409-412
-
-
Kawamori, T.1
Rao, C.V.2
Seibert, K.3
Reddy, B.S.4
-
10
-
-
0030019753
-
Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam
-
Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tutsch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR, Dove WF: Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res 56(4): 710-714, 1996
-
(1996)
Cancer Res
, vol.56
, Issue.4
, pp. 710-714
-
-
Jacoby, R.F.1
Marshall, D.J.2
Newton, M.A.3
Novakovic, K.4
Tutsch, K.5
Cole, C.E.6
Lubet, R.A.7
Kelloff, G.J.8
Verma, A.9
Moser, A.R.10
Dove, W.F.11
-
11
-
-
0031823483
-
The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis
-
Mahmoud NN, Boolbol SK, Dannenberg AJ, Mestre JR, Bilinski RT, Martucci C, Newmark HL, Chadburn A, Bertagnolli MM: The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis 19(1): 87-91, 1998
-
(1998)
Carcinogenesis
, vol.19
, Issue.1
, pp. 87-91
-
-
Mahmoud, N.N.1
Boolbol, S.K.2
Dannenberg, A.J.3
Mestre, J.R.4
Bilinski, R.T.5
Martucci, C.6
Newmark, H.L.7
Chadburn, A.8
Bertagnolli, M.M.9
-
12
-
-
0027197062
-
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
-
Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328(18): 1313-1316, 1993
-
(1993)
N Engl J Med
, vol.328
, Issue.18
, pp. 1313-1316
-
-
Giardiello, F.M.1
Hamilton, S.R.2
Krush, A.J.3
Piantadosi, S.4
Hylind, L.M.5
Celano, P.6
Booker, S.V.7
Robinson, C.R.8
Offerhaus, G.J.9
-
13
-
-
17744418769
-
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
-
Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342(26): 1946-1952, 2000
-
(2000)
N Engl J Med
, vol.342
, Issue.26
, pp. 1946-1952
-
-
Steinbach, G.1
Lynch, P.M.2
Phillips, R.K.3
Wallace, M.H.4
Hawk, E.5
Gordon, G.B.6
Wakabayashi, N.7
Saunders, B.8
Shen, Y.9
Fujimura, T.10
Su, L.K.11
Levin, B.12
-
14
-
-
0033971402
-
Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
-
Feldman M, McMahon AT: Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med 132(2): 134-143, 2001
-
(2001)
Ann Intern Med
, vol.132
, Issue.2
, pp. 134-143
-
-
Feldman, M.1
McMahon, A.T.2
-
15
-
-
0034707105
-
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
-
VIGOR Study Group
-
Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343(21): 1520-1528, 2000
-
(2000)
N Engl J Med
, vol.343
, Issue.21
, pp. 1520-1528
-
-
Bombardier, C.1
Laine, L.2
Reicin, A.3
Shapiro, D.4
Burgos-Vargas, R.5
Davis, B.6
Day, R.7
Ferraz, M.B.8
Hawkey, C.J.9
Hochberg, M.C.10
Kvien, T.K.11
Schnitzer, T.J.12
-
16
-
-
0033791318
-
Cyclooxygenases: Structural, cellular, and molecular biology
-
Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182, 2000
-
(2000)
Annu Rev Biochem
, vol.69
, pp. 145-182
-
-
Smith, W.L.1
DeWitt, D.L.2
Garavito, R.M.3
-
17
-
-
0031689543
-
Cyclooxygenase in biology and disease
-
Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE: Cyclooxygenase in biology and disease. Faseb J 12(12): 1063-1073, 1998
-
(1998)
Faseb J
, vol.12
, Issue.12
, pp. 1063-1073
-
-
Dubois, R.N.1
Abramson, S.B.2
Crofford, L.3
Gupta, R.A.4
Simon, L.S.5
Van De Putte, L.B.6
Lipsky, P.E.7
-
18
-
-
0029583372
-
Inflammation, reproduction, cancer and all that... The regulation and role of the inducible prostaglandin synthase
-
Herschman HR, Xie W, Reddy S: Inflammation, reproduction, cancer and all that.... The regulation and role of the inducible prostaglandin synthase. Bioessays 17(12): 1031-1037, 1995
-
(1995)
Bioessays
, vol.17
, Issue.12
, pp. 1031-1037
-
-
Herschman, H.R.1
Xie, W.2
Reddy, S.3
-
19
-
-
0030049390
-
Prostaglandin synthase 2
-
Herschman HR: Prostaglandin synthase 2. Biochim Biophys Acta 1299(1): 125-140, 1996
-
(1996)
Biochim Biophys Acta
, vol.1299
, Issue.1
, pp. 125-140
-
-
Herschman, H.R.1
-
20
-
-
0025754779
-
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
-
Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88(7): 2692-2696, 1991
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, Issue.7
, pp. 2692-2696
-
-
Xie, W.L.1
Chipman, J.G.2
Robertson, D.L.3
Erikson, R.L.4
Simmons, D.L.5
-
21
-
-
0025871150
-
TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
-
Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266(20): 12866-12872, 1991
-
(1991)
J Biol Chem
, vol.266
, Issue.20
, pp. 12866-12872
-
-
Kujubu, D.A.1
Fletcher, B.S.2
Varnum, B.C.3
Lim, R.W.4
Herschman, H.R.5
-
22
-
-
0026730021
-
Human cyclooxygenase-2 cDNA
-
Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89(16): 7384-7388, 1992
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, Issue.16
, pp. 7384-7388
-
-
Hla, T.1
Neilson, K.2
-
23
-
-
0034671806
-
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
-
Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT: COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89(12): 2637-2645, 2000
-
(2000)
Cancer
, vol.89
, Issue.12
, pp. 2637-2645
-
-
Soslow, R.A.1
Dannenberg, A.J.2
Rush, D.3
Woerner, B.M.4
Khan, K.N.5
Masferrer, J.6
Koki, A.T.7
-
24
-
-
0035833502
-
The coxibs, selective inhibitors of cyclooxygenase-2
-
FitzGerald GA, Patrono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345(6): 433-442, 2001
-
(2001)
N Engl J Med
, vol.345
, Issue.6
, pp. 433-442
-
-
FitzGerald, G.A.1
Patrono, C.2
-
25
-
-
0032702213
-
Cyclooxygenase 2 inhibitors: Discovery, selectivity and the future
-
Marnett LJ, Kalgutkar AS: Cyclooxygenase 2 inhibitors: Discovery, selectivity and the future. Trends Pharmacol Sci 20(11): 465-469, 1999
-
(1999)
Trends Pharmacol Sci
, vol.20
, Issue.11
, pp. 465-469
-
-
Marnett, L.J.1
Kalgutkar, A.S.2
-
26
-
-
0032815687
-
Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers
-
Sinicrope FA, Lemoine M, Xi L, Lynch PM, Cleary KR, Shen Y, Frazier ML: Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers. Gastroenterology 117(2): 350-358, 1999
-
(1999)
Gastroenterology
, vol.117
, Issue.2
, pp. 350-358
-
-
Sinicrope, F.A.1
Lemoine, M.2
Xi, L.3
Lynch, P.M.4
Cleary, K.R.5
Shen, Y.6
Frazier, M.L.7
-
27
-
-
0029117472
-
Expression of cyclooxygenase-1 and -2 in human colorectal cancer
-
Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T: Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55(17): 3785-3789, 1995
-
(1995)
Cancer Res
, vol.55
, Issue.17
, pp. 3785-3789
-
-
Sano, H.1
Kawahito, Y.2
Wilder, R.L.3
Hashiramoto, A.4
Mukai, S.5
Asai, K.6
Kimura, S.7
Kato, H.8
Kondo, M.9
Hla, T.10
-
28
-
-
0029008617
-
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
-
Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S: Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55(12): 2556-2559, 1995
-
(1995)
Cancer Res
, vol.55
, Issue.12
, pp. 2556-2559
-
-
Kargman, S.L.1
O'Neill, G.P.2
Vickers, P.J.3
Evans, J.F.4
Mancini, J.A.5
Jothy, S.6
-
29
-
-
0032833473
-
High expression of cyclooxygenase-2 in macrophages of human colonic adenoma
-
Bamba H, Ota S, Kato A, Adachi A, Itoyama S, Matsuzaki F: High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int J Cancer 83(4): 470-475, 1999
-
(1999)
Int J Cancer
, vol.83
, Issue.4
, pp. 470-475
-
-
Bamba, H.1
Ota, S.2
Kato, A.3
Adachi, A.4
Itoyama, S.5
Matsuzaki, F.6
-
30
-
-
0033889233
-
Localization of cyclooxygenase-2 in human sporadic colorectal adenomas
-
Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor AC, Guillou PJ, Markham AF, Coletta PL, Hull MA: Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 156(2): 545-553, 2000
-
(2000)
Am J Pathol
, vol.156
, Issue.2
, pp. 545-553
-
-
Chapple, K.S.1
Cartwright, E.J.2
Hawcroft, G.3
Tisbury, A.4
Bonifer, C.5
Scott, N.6
Windsor, A.C.7
Guillou, P.J.8
Markham, A.F.9
Coletta, P.L.10
Hull, M.A.11
-
31
-
-
0034161878
-
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
-
Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60(5): 1306-1311, 2000
-
(2000)
Cancer Res
, vol.60
, Issue.5
, pp. 1306-1311
-
-
Masferrer, J.L.1
Leahy, K.M.2
Koki, A.T.3
Zweifel, B.S.4
Settle, S.L.5
Woerner, B.M.6
Edwards, D.A.7
Flickinger, A.G.8
Moore, R.J.9
Seibert, K.10
-
32
-
-
0036468899
-
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer
-
Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J: Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62(3): 632-635, 2002
-
(2002)
Cancer Res
, vol.62
, Issue.3
, pp. 632-635
-
-
Ristimaki, A.1
Sivula, A.2
Lundin, J.3
Lundin, M.4
Salminen, T.5
Haglund, C.6
Joensuu, H.7
Isola, J.8
-
33
-
-
0037086261
-
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ
-
Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA: Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res 62(6): 1676-1681, 2002
-
(2002)
Cancer Res
, vol.62
, Issue.6
, pp. 1676-1681
-
-
Half, E.1
Tang, X.M.2
Gwyn, K.3
Sahin, A.4
Wathen, K.5
Sinicrope, F.A.6
-
34
-
-
0033199017
-
Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
-
Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA: Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 59(17): 4356-4362, 1999
-
(1999)
Cancer Res
, vol.59
, Issue.17
, pp. 4356-4362
-
-
Molina, M.A.1
Sitja-Arnau, M.2
Lemoine, M.G.3
Frazier, M.L.4
Sinicrope, F.A.5
-
35
-
-
0033106051
-
Cyclooxygenase-2 expression is upregulated in human pancreatic cancer
-
Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ: 3rd, Cyclooxygenase-2 expression is upregulated in human pancreatic cancer. Cancer Res 59(5): 987-990, 1999
-
(1999)
Cancer Res
, vol.59
, Issue.5
, pp. 987-990
-
-
Tucker, O.N.1
Dannenberg, A.J.2
Yang, E.K.3
Zhang, F.4
Teng, L.5
Daly, J.M.6
Soslow, R.A.7
Masferrer, J.L.8
Woerner, B.M.9
Koki, A.T.10
Fahey III, T.J.11
-
36
-
-
0033173218
-
Cyclooxygenase-2 in Barrett's esophagus, Barrett's adenocarcinomas, and esophageal SCC: Ready for clinical trials
-
Lord RV, Danenberg KD, Danenberg PV: Cyclooxygenase-2 in Barrett's esophagus, Barrett's adenocarcinomas, and esophageal SCC: Ready for clinical trials. Am J Gastroenterol 94(8): 2313-2315, 1999
-
(1999)
Am J Gastroenterol
, vol.94
, Issue.8
, pp. 2313-2315
-
-
Lord, R.V.1
Danenberg, K.D.2
Danenberg, P.V.3
-
37
-
-
18144438592
-
Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus
-
Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y, Yano M, Inoue M, Matsuura N, Shiozaki H, Monden M: Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 6(4): 1229-1238, 2000
-
(2000)
Clin Cancer Res
, vol.6
, Issue.4
, pp. 1229-1238
-
-
Shamma, A.1
Yamamoto, H.2
Doki, Y.3
Okami, J.4
Kondo, M.5
Fujiwara, Y.6
Yano, M.7
Inoue, M.8
Matsuura, N.9
Shiozaki, H.10
Monden, M.11
-
38
-
-
0036156229
-
Cyclooxygenase-2 expression during carcinogenesis in the human stomach
-
van Rees BP, Saukkonen K, Ristimaki A, Polkowski W, Tytgat GN, Drillenburg P, Offerhaus GJ: Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J Pathol 196(2): 171-179, 2002
-
(2002)
J Pathol
, vol.196
, Issue.2
, pp. 171-179
-
-
Van Rees, B.P.1
Saukkonen, K.2
Ristimaki, A.3
Polkowski, W.4
Tytgat, G.N.5
Drillenburg, P.6
Offerhaus, G.J.7
-
39
-
-
0036229792
-
Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia
-
Yamagata R, Shimoyama T, Fukuda S, Yoshimura T, Tanaka M, Munakata A: Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur J Gastroenterol Hepatol 14(4): 359-363, 2002
-
(2002)
Eur J Gastroenterol Hepatol
, vol.14
, Issue.4
, pp. 359-363
-
-
Yamagata, R.1
Shimoyama, T.2
Fukuda, S.3
Yoshimura, T.4
Tanaka, M.5
Munakata, A.6
-
40
-
-
0032533858
-
Expression of cyclooxygenase-2 in human lung carcinoma
-
Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58(22): 4997-5001, 1998
-
(1998)
Cancer Res
, vol.58
, Issue.22
, pp. 4997-5001
-
-
Wolff, H.1
Saukkonen, K.2
Anttila, S.3
Karjalainen, A.4
Vainio, H.5
Ristimaki, A.6
-
41
-
-
0032927779
-
Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors
-
Shao J, Sheng H, Aramandla R, Pereira MA, Lubet RA, Hawk E, Grogan L, Kirsch IR, Washington MK, Beauchamp RD, DuBois RN: Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis 20(2): 185-191, 1999
-
(1999)
Carcinogenesis
, vol.20
, Issue.2
, pp. 185-191
-
-
Shao, J.1
Sheng, H.2
Aramandla, R.3
Pereira, M.A.4
Lubet, R.A.5
Hawk, E.6
Grogan, L.7
Kirsch, I.R.8
Washington, M.K.9
Beauchamp, R.D.10
DuBois, R.N.11
-
42
-
-
0033918259
-
Differential expression of cyclooxygenase 2 in human colorectal cancer
-
Hull M, Langman M: Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 47(1): 154, 2000
-
(2000)
Gut
, vol.47
, Issue.1
, pp. 154
-
-
Hull, M.1
Langman, M.2
-
43
-
-
0033959884
-
Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice
-
Shattuck-Brandt RL, Varilek GW, Radhika A, Yang F, Washington MK, DuBois RN: Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice. Gastroenterology 118(2): 337-345, 2000
-
(2000)
Gastroenterology
, vol.118
, Issue.2
, pp. 337-345
-
-
Shattuck-Brandt, R.L.1
Varilek, G.W.2
Radhika, A.3
Yang, F.4
Washington, M.K.5
DuBois, R.N.6
-
44
-
-
0034089566
-
Host cyclooxygenase-2 modulates carcinoma growth
-
Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN: Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 105(11): 1589-1594, 2000
-
(2000)
J Clin Invest
, vol.105
, Issue.11
, pp. 1589-1594
-
-
Williams, C.S.1
Tsujii, M.2
Reese, J.3
Dey, S.K.4
DuBois, R.N.5
-
45
-
-
0036895867
-
Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps
-
Sonoshita M, Takaku K, Oshima M, Sugihara K, Taketo MM: Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res 62(23): 6846-6849, 2002
-
(2002)
Cancer Res
, vol.62
, Issue.23
, pp. 6846-6849
-
-
Sonoshita, M.1
Takaku, K.2
Oshima, M.3
Sugihara, K.4
Taketo, M.M.5
-
46
-
-
3643084354
-
Reduced COX-2 protein in colorectal cancer with defective mismatch repair
-
Karnes WE, Jr. Shattuck-Brandt R, Burgart LJ, DuBois RN, Tester DJ, Cunningham JM, Kim CY, McDonnell SK, Schaid DJ, Thibodeau SN: Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res 58(23): 5473-5477, 1998
-
(1998)
Cancer Res
, vol.58
, Issue.23
, pp. 5473-5477
-
-
Karnes Jr., W.E.1
Shattuck-Brandt, R.2
Burgart, L.J.3
DuBois, R.N.4
Tester, D.J.5
Cunningham, J.M.6
Kim, C.Y.7
McDonnell, S.K.8
Schaid, D.J.9
Thibodeau, S.N.10
-
47
-
-
0032146118
-
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability
-
Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58(15): 3455-3460, 1998
-
(1998)
Cancer Res
, vol.58
, Issue.15
, pp. 3455-3460
-
-
Cunningham, J.M.1
Christensen, E.R.2
Tester, D.J.3
Kim, C.Y.4
Roche, P.C.5
Burgart, L.J.6
Thibodeau, S.N.7
-
48
-
-
0033894117
-
Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors
-
Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa JP: Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res 60(15): 4044-4048, 2000
-
(2000)
Cancer Res
, vol.60
, Issue.15
, pp. 4044-4048
-
-
Toyota, M.1
Shen, L.2
Ohe-Toyota, M.3
Hamilton, S.R.4
Sinicrope, F.A.5
Issa, J.P.6
-
49
-
-
0034681117
-
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
-
Toyota M, Ohe-Toyota M, Ahuja N, Issa JP: Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci USA 97(2): 710-715, 2000
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, Issue.2
, pp. 710-715
-
-
Toyota, M.1
Ohe-Toyota, M.2
Ahuja, N.3
Issa, J.P.4
-
50
-
-
0035881311
-
Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor
-
Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S: Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Cancer Res 61(16): 6131-6136, 2001
-
(2001)
Cancer Res
, vol.61
, Issue.16
, pp. 6131-6136
-
-
Lal, G.1
Ash, C.2
Hay, K.3
Redston, M.4
Kwong, E.5
Hancock, B.6
Mak, T.7
Kargman, S.8
Evans, J.F.9
Gallinger, S.10
-
51
-
-
0033530260
-
The relationship between cyclooxygenase-2 expression and colorectal cancer
-
Sheehan KM, Sheahan K, O'Donoghue DP, MacSweeney F, Conroy RM, Fitzgerald DJ, Murray FE: The relationship between cyclooxygenase-2 expression and colorectal cancer. Jama 282(13): 1254-1257, 1999
-
(1999)
Jama
, vol.282
, Issue.13
, pp. 1254-1257
-
-
Sheehan, K.M.1
Sheahan, K.2
O'Donoghue, D.P.3
MacSweeney, F.4
Conroy, R.M.5
Fitzgerald, D.J.6
Murray, F.E.7
-
52
-
-
0028200879
-
Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents
-
Pereira MA, Barnes LH, Rassman VL, Kelloff GV, Steele VE: Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15(5): 1049-1054, 1994
-
(1994)
Carcinogenesis
, vol.15
, Issue.5
, pp. 1049-1054
-
-
Pereira, M.A.1
Barnes, L.H.2
Rassman, V.L.3
Kelloff, G.V.4
Steele, V.E.5
-
53
-
-
0034650771
-
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
-
Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV: Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 60(2): 293-297, 2000
-
(2000)
Cancer Res
, vol.60
, Issue.2
, pp. 293-297
-
-
Reddy, B.S.1
Hirose, Y.2
Lubet, R.3
Steele, V.4
Kelloff, G.5
Paulson, S.6
Seibert, K.7
Rao, C.V.8
-
54
-
-
9344257283
-
Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
-
Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ, Bertagnolli MM: Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56(11): 2556-2560, 1996
-
(1996)
Cancer Res
, vol.56
, Issue.11
, pp. 2556-2560
-
-
Boolbol, S.K.1
Dannenberg, A.J.2
Chadburn, A.3
Martucci, C.4
Guo, X.J.5
Ramonetti, J.T.6
Abreu-Goris, M.7
Newmark, H.L.8
Lipkin, M.L.9
DeCosse, J.J.10
Bertagnolli, M.M.11
-
55
-
-
0034665122
-
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis
-
Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA: The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 60(18): 5040-5044, 2000
-
(2000)
Cancer Res
, vol.60
, Issue.18
, pp. 5040-5044
-
-
Jacoby, R.F.1
Seibert, K.2
Cole, C.E.3
Kelloff, G.4
Lubet, R.A.5
-
56
-
-
0035866401
-
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor
-
Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E, Taketo MM, Evans JF: Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 61(4): 1733-1740, 2001
-
(2001)
Cancer Res
, vol.61
, Issue.4
, pp. 1733-1740
-
-
Oshima, M.1
Murai, N.2
Kargman, S.3
Arguello, M.4
Luk, P.5
Kwong, E.6
Taketo, M.M.7
Evans, J.F.8
-
57
-
-
0035947709
-
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
-
Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T: Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276(21): 18563-18569, 2001
-
(2001)
J Biol Chem
, vol.276
, Issue.21
, pp. 18563-18569
-
-
Liu, C.H.1
Chang, S.H.2
Narko, K.3
Trifan, O.C.4
Wu, M.T.5
Smith, E.6
Haudenschild, C.7
Lane, T.F.8
Hla, T.9
-
58
-
-
0035912711
-
Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin
-
Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K: Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci USA 98(13): 7629-7634, 2001
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, Issue.13
, pp. 7629-7634
-
-
Neufang, G.1
Furstenberger, G.2
Heidt, M.3
Marks, F.4
Muller-Decker, K.5
-
59
-
-
0028941441
-
Inhibition of apoptosis during development of colorectal cancer
-
Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ: Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55(9): 1811-1816, 1995
-
(1995)
Cancer Res
, vol.55
, Issue.9
, pp. 1811-1816
-
-
Bedi, A.1
Pasricha, P.J.2
Akhtar, A.J.3
Barber, J.P.4
Bedi, G.C.5
Giardiello, F.M.6
Zehnbauer, B.A.7
Hamilton, S.R.8
Jones, R.J.9
-
60
-
-
0030458010
-
Increased apoptosis accompanies neoplastic development in the human colorectum
-
Sinicrope FA, Roddey G, McDonnell TJ, Shen Y, Cleary KR, Stephens LC: Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res 2(12): 1999-2006, 1996
-
(1996)
Clin Cancer Res
, vol.2
, Issue.12
, pp. 1999-2006
-
-
Sinicrope, F.A.1
Roddey, G.2
McDonnell, T.J.3
Shen, Y.4
Cleary, K.R.5
Stephens, L.C.6
-
61
-
-
0029825362
-
Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling
-
Moss SF, Scholes JV, Holt PR: Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling. Dig Dis Sci 41(11): 2238-2247, 1996
-
(1996)
Dig Dis Sci
, vol.41
, Issue.11
, pp. 2238-2247
-
-
Moss, S.F.1
Scholes, J.V.2
Holt, P.R.3
-
62
-
-
0028803728
-
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
-
Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83(3): 493-501, 1995
-
(1995)
Cell
, vol.83
, Issue.3
, pp. 493-501
-
-
Tsujii, M.1
DuBois, R.N.2
-
63
-
-
0036829336
-
Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells
-
Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA: Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res 62(21): 6323-6328, 2002
-
(2002)
Cancer Res
, vol.62
, Issue.21
, pp. 6323-6328
-
-
Sun, Y.1
Tang, X.M.2
Half, E.3
Kuo, M.T.4
Sinicrope, F.A.5
-
64
-
-
0036735391
-
Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis- inducing ligand-induced apoptosis in human colon cancer cells
-
Tang X, Sun YJ, Half E, Kuo MT, Sinicrope F: Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Cancer Res 62(17): 4903-4908, 2002
-
(2002)
Cancer Res
, vol.62
, Issue.17
, pp. 4903-4908
-
-
Tang, X.1
Sun, Y.J.2
Half, E.3
Kuo, M.T.4
Sinicrope, F.5
-
65
-
-
0037026582
-
Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells
-
He Q, Luo X, Huang Y, Sheikh MS: Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells. Oncogene 21(39): 6032-6040, 2002
-
(2002)
Oncogene
, vol.21
, Issue.39
, pp. 6032-6040
-
-
He, Q.1
Luo, X.2
Huang, Y.3
Sheikh, M.S.4
-
66
-
-
0032901304
-
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms
-
Shattuck-Brandt RL, Lamps LW, Heppner Goss KJ, DuBois RN, Matrisian LM: Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Mol Carcinog 24(3): 177-187, 1999
-
(1999)
Mol Carcinog
, vol.24
, Issue.3
, pp. 177-187
-
-
Shattuck-Brandt, R.L.1
Lamps, L.W.2
Heppner Goss, K.J.3
DuBois, R.N.4
Matrisian, L.M.5
-
67
-
-
0030952695
-
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
-
Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94(7): 3336-3340, 1997
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, Issue.7
, pp. 3336-3340
-
-
Tsujii, M.1
Kawano, S.2
DuBois, R.N.3
-
68
-
-
0036926092
-
Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells
-
Li G, Yang T, Yan J: Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem Biophys Res Commun 299(5): 886-886, 2002
-
(2002)
Biochem Biophys Res Commun
, vol.299
, Issue.5
, pp. 886-886
-
-
Li, G.1
Yang, T.2
Yan, J.3
-
69
-
-
0034662627
-
Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases
-
Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, Patierno SR: Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 60(16): 4629-4637, 2000
-
(2000)
Cancer Res
, vol.60
, Issue.16
, pp. 4629-4637
-
-
Attiga, F.A.1
Fernandez, P.M.2
Weeraratna, A.T.3
Manyak, M.J.4
Patierno, S.R.5
-
70
-
-
0020967295
-
Effects of prostaglandin synthesis inhibitors on tumor growth and vascularization. Experimental studies in the rat
-
Peterson HI: Effects of prostaglandin synthesis inhibitors on tumor growth and vascularization. Experimental studies in the rat. Invasion Metastasis 3(3): 151-159, 1983
-
(1983)
Invasion Metastasis
, vol.3
, Issue.3
, pp. 151-159
-
-
Peterson, H.I.1
-
71
-
-
0032750920
-
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
-
Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS: Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5(12): 1418-1423, 1999
-
(1999)
Nat Med
, vol.5
, Issue.12
, pp. 1418-1423
-
-
Jones, M.K.1
Wang, H.2
Peskar, B.M.3
Levin, E.4
Itani, R.M.5
Sarfeh, I.J.6
Tarnawski, A.S.7
-
72
-
-
0003504049
-
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
-
Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93(5): 705-716, 1998
-
(1998)
Cell
, vol.93
, Issue.5
, pp. 705-716
-
-
Tsujii, M.1
Kawano, S.2
Tsuji, S.3
Sawaoka, H.4
Hori, M.5
DuBois, R.N.6
-
73
-
-
0034029780
-
Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants
-
Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M: Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol 130(3): 641-649, 2000
-
(2000)
Br J Pharmacol
, vol.130
, Issue.3
, pp. 641-649
-
-
Majima, M.1
Hayashi, I.2
Muramatsu, M.3
Katada, J.4
Yamashina, S.5
Katori, M.6
-
74
-
-
0035207130
-
Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer
-
Cianchi F, Cortesini C, Bechi P, Fantappie O, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mazzanti R, Masini E: Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 121(6): 1339-1347, 2001
-
(2001)
Gastroenterology
, vol.121
, Issue.6
, pp. 1339-1347
-
-
Cianchi, F.1
Cortesini, C.2
Bechi, P.3
Fantappie, O.4
Messerini, L.5
Vannacci, A.6
Sardi, I.7
Baroni, G.8
Boddi, V.9
Mazzanti, R.10
Masini, E.11
-
75
-
-
0033567459
-
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis
-
Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ: Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59(18): 4574-4577, 1999
-
(1999)
Cancer Res
, vol.59
, Issue.18
, pp. 4574-4577
-
-
Daniel, T.O.1
Liu, H.2
Morrow, J.D.3
Crews, B.C.4
Marnett, L.J.5
-
76
-
-
0034282465
-
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice
-
Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, Tiano HF, Morham SG, Smithies O, Langenbach R: Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 60(17): 4705-4708, 2000
-
(2000)
Cancer Res
, vol.60
, Issue.17
, pp. 4705-4708
-
-
Chulada, P.C.1
Thompson, M.B.2
Mahler, J.F.3
Doyle, C.M.4
Gaul, B.W.5
Lee, C.6
Tiano, H.F.7
Morham, S.G.8
Smithies, O.9
Langenbach, R.10
-
77
-
-
0030879456
-
Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression
-
Elder DJ, Halton DE, Hague A, Paraskeva C: Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression Clin Cancer Res 3(10): 1679-1683, 1997
-
(1997)
Clin Cancer Res
, vol.3
, Issue.10
, pp. 1679-1683
-
-
Elder, D.J.1
Halton, D.E.2
Hague, A.3
Paraskeva, C.4
-
78
-
-
0030947525
-
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
-
Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN: Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99(9): 2254-2259, 1997
-
(1997)
J Clin Invest
, vol.99
, Issue.9
, pp. 2254-2259
-
-
Sheng, H.1
Shao, J.2
Kirkland, S.C.3
Isakson, P.4
Coffey, R.J.5
Morrow, J.6
Beauchamp, R.D.7
DuBois, R.N.8
-
79
-
-
0029115954
-
Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
-
Shiff SJ, Qiao L, Tsai LL, Rigas B: Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96(1): 491-503, 1995
-
(1995)
J Clin Invest
, vol.96
, Issue.1
, pp. 491-503
-
-
Shiff, S.J.1
Qiao, L.2
Tsai, L.L.3
Rigas, B.4
-
80
-
-
0029035070
-
Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
-
Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R, et al.: Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55(14): 3110-3116, 1995
-
(1995)
Cancer Res
, vol.55
, Issue.14
, pp. 3110-3116
-
-
Piazza, G.A.1
Rahm, A.L.2
Krutzsch, M.3
Sperl, G.4
Paranka, N.S.5
Gross, P.H.6
Brendel, K.7
Burt, R.W.8
Alberts, D.S.9
Pamukcu, R.10
-
81
-
-
0034326837
-
Celecoxib prevents tumor growth in vivo without toxicity to normal gut: Lack of correlation between in vitro and in vivo models
-
Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN: Celecoxib prevents tumor growth in vivo without toxicity to normal gut: Lack of correlation between in vitro and in vivo models. Cancer Res 60(21): 6045-6051, 2000
-
(2000)
Cancer Res
, vol.60
, Issue.21
, pp. 6045-6051
-
-
Williams, C.S.1
Watson, A.J.2
Sheng, H.3
Helou, R.4
Shao, J.5
DuBois, R.N.6
-
82
-
-
0031000902
-
Modulation of apoptosis by sulindac, curcumin, phenylethyl-3- methylcaffeate, and 6-phenylhexyl isothiocyanate: Apoptotic index as a biomarker in colon cancer chemoprevention and promotion
-
Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS: Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: Apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57(7): 1301-1305, 1997
-
(1997)
Cancer Res
, vol.57
, Issue.7
, pp. 1301-1305
-
-
Samaha, H.S.1
Kelloff, G.J.2
Steele, V.3
Rao, C.V.4
Reddy, B.S.5
-
83
-
-
0000367992
-
Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac
-
Keller JJ, Offerhaus GJ, Polak M, Goodman SN, Zahurak ML, Hylind LM, Hamilton SR, Giardiello FM: Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Gut 45(6): 822-828, 1999
-
(1999)
Gut
, vol.45
, Issue.6
, pp. 822-828
-
-
Keller, J.J.1
Offerhaus, G.J.2
Polak, M.3
Goodman, S.N.4
Zahurak, M.L.5
Hylind, L.M.6
Hamilton, S.R.7
Giardiello, F.M.8
-
84
-
-
1242288664
-
Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controled trial of celecoxib in familial adenomatous polyposis (FAP) Patients
-
Sinicrope FA, Half E, Lynch PM, Morrow J, Levin B, Ayers G, Morris J, Hawk E, Stephens LC: Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controled trial of celecoxib in familial adenomatous polyposis (FAP) Patients. Proc of Digestive Diseases Week, 2003
-
(2003)
Proc of Digestive Diseases Week
-
-
Sinicrope, F.A.1
Half, E.2
Lynch, P.M.3
Morrow, J.4
Levin, B.5
Ayers, G.6
Morris, J.7
Hawk, E.8
Stephens, L.C.9
-
85
-
-
0034602188
-
Role of BAX in the apoptotic response to anticancer agents
-
Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B: Role of BAX in the apoptotic response to anticancer agents. Science 290(5493): 989-992, 2000
-
(2000)
Science
, vol.290
, Issue.5493
, pp. 989-992
-
-
Zhang, L.1
Yu, J.2
Park, B.H.3
Kinzler, K.W.4
Vogelstein, B.5
-
86
-
-
0030602860
-
Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
-
Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B: Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 52(2): 237-245, 1996
-
(1996)
Biochem Pharmacol
, vol.52
, Issue.2
, pp. 237-245
-
-
Hanif, R.1
Pittas, A.2
Feng, Y.3
Koutsos, M.I.4
Qiao, L.5
Staiano-Coico, L.6
Shiff, S.I.7
Rigas, B.8
-
87
-
-
0033575760
-
Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts
-
Zhang X, Morham SG, Langenbach R, Young DA: Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med 190(4): 451-459, 1999
-
(1999)
J Exp Med
, vol.190
, Issue.4
, pp. 451-459
-
-
Zhang, X.1
Morham, S.G.2
Langenbach, R.3
Young, D.A.4
-
88
-
-
12644261426
-
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells
-
Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ, Chinery R, Kirkland SC, DuBois RN, Jetton TL, Morrow JD: Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci USA 94(2): 657-662, 1997
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, Issue.2
, pp. 657-662
-
-
Coffey, R.J.1
Hawkey, C.J.2
Damstrup, L.3
Graves-Deal, R.4
Daniel, V.C.5
Dempsey, P.J.6
Chinery, R.7
Kirkland, S.C.8
DuBois, R.N.9
Jetton, T.L.10
Morrow, J.D.11
-
89
-
-
0034019416
-
Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non- Steroidal anti-inflammatory drug NS-398
-
Elder DJ, Halton DE, Crew TE, Paraskeva C: Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int J Cancer 86(4): 553-560, 2000
-
(2000)
Int J Cancer
, vol.86
, Issue.4
, pp. 553-560
-
-
Elder, D.J.1
Halton, D.E.2
Crew, T.E.3
Paraskeva, C.4
-
90
-
-
0030747817
-
Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
-
Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, Sperl G, Ritchie J, Burt RW, Ellsworth L, Ahnen DJ, Pamukcu R: Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 57(14): 2909-2915, 1997
-
(1997)
Cancer Res
, vol.57
, Issue.14
, pp. 2909-2915
-
-
Piazza, G.A.1
Alberts, D.S.2
Hixson, L.J.3
Paranka, N.S.4
Li, H.5
Finn, T.6
Bogert, C.7
Guillen, J.M.8
Brendel, K.9
Gross, P.H.10
Sperl, G.11
Ritchie, J.12
Burt, R.W.13
Ellsworth, L.14
Ahnen, D.J.15
Pamukcu, R.16
-
91
-
-
0029451275
-
Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?
-
Alberts DS, Hixson L, Ahnen D, Bogert C, Einspahr J, Paranka N, Brendel K, Gross PH, Pamukcu R, Burt RW: Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J Cell Biochem Suppl 22: 18-23, 1995
-
(1995)
J Cell Biochem Suppl
, vol.22
, pp. 18-23
-
-
Alberts, D.S.1
Hixson, L.2
Ahnen, D.3
Bogert, C.4
Einspahr, J.5
Paranka, N.6
Brendel, K.7
Gross, P.H.8
Pamukcu, R.9
Burt, R.W.10
-
92
-
-
0028167846
-
Inhibition of NF-kappa B by sodium salicylate and aspirin
-
Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265(5174): 956-959, 1994
-
(1994)
Science
, vol.265
, Issue.5174
, pp. 956-959
-
-
Kopp, E.1
Ghosh, S.2
-
93
-
-
0033578879
-
Sulindac inhibits activation of the NF-kappaB pathway
-
Yamamoto Y, Yin MJ, Lin KM, Gaynor RB: Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem 274(38): 27307-27314, 1999
-
(1999)
J Biol Chem
, vol.274
, Issue.38
, pp. 27307-27314
-
-
Yamamoto, Y.1
Yin, M.J.2
Lin, K.M.3
Gaynor, R.B.4
-
94
-
-
0032487857
-
The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta
-
Yin MJ, Yamamoto Y, Gaynor RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396(6706): 77-80, 1998
-
(1998)
Nature
, vol.396
, Issue.6706
, pp. 77-80
-
-
Yin, M.J.1
Yamamoto, Y.2
Gaynor, R.B.3
-
95
-
-
0031013395
-
Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs
-
Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA: Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272(6): 3406-3410, 1997
-
(1997)
J Biol Chem
, vol.272
, Issue.6
, pp. 3406-3410
-
-
Lehmann, J.M.1
Lenhard, J.M.2
Oliver, B.B.3
Ringold, G.M.4
Kliewer, S.A.5
-
96
-
-
0033615352
-
PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
-
He TC, Chan TA, Vogelstein B, Kinzler KW: PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99(3): 335-345, 1999
-
(1999)
Cell
, vol.99
, Issue.3
, pp. 335-345
-
-
He, T.C.1
Chan, T.A.2
Vogelstein, B.3
Kinzler, K.W.4
-
97
-
-
0035956850
-
Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells
-
Park BH, Vogelstein B, Kinzler KW: Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci USA 98(5): 2598-2603, 2001
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, Issue.5
, pp. 2598-2603
-
-
Park, B.H.1
Vogelstein, B.2
Kinzler, K.W.3
-
98
-
-
0030025365
-
Nonsteroidal antiinflammatory drugs and breast cancer
-
Harris RE, Namboodiri KK, Farrar WB: Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7(2): 203-205, 1996
-
(1996)
Epidemiology
, vol.7
, Issue.2
, pp. 203-205
-
-
Harris, R.E.1
Namboodiri, K.K.2
Farrar, W.B.3
-
99
-
-
0034039306
-
Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage
-
Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA: Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 83(1): 112-120, 2000
-
(2000)
Br J Cancer
, vol.83
, Issue.1
, pp. 112-120
-
-
Sharpe, C.R.1
Collet, J.P.2
McNutt, M.3
Belzile, E.4
Boivin, J.F.5
Hanley, J.A.6
-
100
-
-
0029998249
-
Prospective study of regular aspirin use and the risk of breast cancer
-
Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA: Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88(14): 988-993, 1996
-
(1996)
J Natl Cancer Inst
, vol.88
, Issue.14
, pp. 988-993
-
-
Egan, K.M.1
Stampfer, M.J.2
Giovannucci, E.3
Rosner, B.A.4
Colditz, G.A.5
-
101
-
-
0036668661
-
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients
-
Ferrandina G, Lauriola L, Zannoni GF, Fagotti A, Fanfani F, Legge F, Maggiano N, Gessi M, Mancuso S, Ranelletti FO, Scambia G: Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. Ann Oncol 13(8): 1205-1211, 2002
-
(2002)
Ann Oncol
, vol.13
, Issue.8
, pp. 1205-1211
-
-
Ferrandina, G.1
Lauriola, L.2
Zannoni, G.F.3
Fagotti, A.4
Fanfani, F.5
Legge, F.6
Maggiano, N.7
Gessi, M.8
Mancuso, S.9
Ranelletti, F.O.10
Scambia, G.11
-
102
-
-
0034901568
-
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer
-
Khuri FR, Wu H, Lee JJ, Kemp BL, Lotan R, Lippman SM, Feng L, Hong WK, Xu XC: Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 7(4): 861-867, 2001
-
(2001)
Clin Cancer Res
, vol.7
, Issue.4
, pp. 861-867
-
-
Khuri, F.R.1
Wu, H.2
Lee, J.J.3
Kemp, B.L.4
Lotan, R.5
Lippman, S.M.6
Feng, L.7
Hong, W.K.8
Xu, X.C.9
-
103
-
-
0036083347
-
Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus
-
Buskens CJ, Van Rees BP, Sivula A, Reitsma JB, Haglund C, Bosma PJ, Offerhaus GJ, Van Lanschot JJ, Ristimaki A: Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology 122(7): 1800-1807, 2002
-
(2002)
Gastroenterology
, vol.122
, Issue.7
, pp. 1800-1807
-
-
Buskens, C.J.1
Van Rees, B.P.2
Sivula, A.3
Reitsma, J.B.4
Haglund, C.5
Bosma, P.J.6
Offerhaus, G.J.7
Van Lanschot, J.J.8
Ristimaki, A.9
-
104
-
-
0029851291
-
Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
-
Liu XH, Rose DP: Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res 56(22): 5125-5127, 1996
-
(1996)
Cancer Res
, vol.56
, Issue.22
, pp. 5125-5127
-
-
Liu, X.H.1
Rose, D.P.2
-
105
-
-
0037166271
-
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: Evidence for involvement of AP-1 and PEA3
-
Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ: Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: Evidence for involvement of AP-1 and PEA3. J Biol Chem 277(21): 18649-18657, 2002
-
(2002)
J Biol Chem
, vol.277
, Issue.21
, pp. 18649-18657
-
-
Subbaramaiah, K.1
Norton, L.2
Gerald, W.3
Dannenberg, A.J.4
-
106
-
-
0036792206
-
Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer
-
Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, Hudis C, Thaler HT, Muller WJ, Du B, Brown AM, Dannenberg AJ: Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res 62(19): 5405-5407, 2002
-
(2002)
Cancer Res
, vol.62
, Issue.19
, pp. 5405-5407
-
-
Howe, L.R.1
Subbaramaiah, K.2
Patel, J.3
Masferrer, J.L.4
Deora, A.5
Hudis, C.6
Thaler, H.T.7
Muller, W.J.8
Du, B.9
Brown, A.M.10
Dannenberg, A.J.11
-
107
-
-
0024548631
-
Sulindac for polyposis of the colon
-
Waddell WR, Ganser GF, Cerise EJ, Loughry RW: Sulindac for polyposis of the colon. Am J Surg 157(1): 175-179, 1989
-
(1989)
Am J Surg
, vol.157
, Issue.1
, pp. 175-179
-
-
Waddell, W.R.1
Ganser, G.F.2
Cerise, E.J.3
Loughry, R.W.4
-
108
-
-
0034644396
-
Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controled trial. Celecoxib Long-term Arthritis Safety Study
-
Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS: Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284(10): 1247-1255, 2000
-
(2000)
JAMA
, vol.284
, Issue.10
, pp. 1247-1255
-
-
Silverstein, F.E.1
Faich, G.2
Goldstein, J.L.3
Simon, L.S.4
Pincus, T.5
Whelton, A.6
Makuch, R.7
Eisen, G.8
Agrawal, N.M.9
Stenson, W.F.10
Burr, A.M.11
Zhao, W.W.12
Kent, J.D.13
Lefkowith, J.B.14
Verburg, K.M.15
Geis, G.S.16
-
109
-
-
0033843672
-
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo
-
Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS: Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. J Rheumatol 27(8): 1876-1883, 2000
-
(2000)
J Rheumatol
, vol.27
, Issue.8
, pp. 1876-1883
-
-
Bensen, W.G.1
Zhao, S.Z.2
Burke, T.A.3
Zabinski, R.A.4
Makuch, R.W.5
Maurath, C.J.6
Agrawal, N.M.7
Geis, G.S.8
-
110
-
-
0033930616
-
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor
-
Goldstein JL, Silverstein FE, Agrawal NM, Hubbard RC, Kaiser J, Maurath CJ, Verburg KM, Geis GS: Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 95(7): 1681-1690, 2000
-
(2000)
Am J Gastroenterol
, vol.95
, Issue.7
, pp. 1681-1690
-
-
Goldstein, J.L.1
Silverstein, F.E.2
Agrawal, N.M.3
Hubbard, R.C.4
Kaiser, J.5
Maurath, C.J.6
Verburg, K.M.7
Geis, G.S.8
-
111
-
-
0034706411
-
Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis
-
Watson DJ, Harper SE, Zhao PL, Quan H, Bolognese JA, Simon TJ: Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis. Arch Intern Med 160(19): 2998-3003, 2000
-
(2000)
Arch Intern Med
, vol.160
, Issue.19
, pp. 2998-3003
-
-
Watson, D.J.1
Harper, S.E.2
Zhao, P.L.3
Quan, H.4
Bolognese, J.A.5
Simon, T.J.6
-
112
-
-
0036789104
-
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis
-
Laine L, Bombardier C, Hawkey CJ, Davis B, Shapiro D, Brett C, Reicin A: Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 123(4): 1006-1012, 2002
-
(2002)
Gastroenterology
, vol.123
, Issue.4
, pp. 1006-1012
-
-
Laine, L.1
Bombardier, C.2
Hawkey, C.J.3
Davis, B.4
Shapiro, D.5
Brett, C.6
Reicin, A.7
-
113
-
-
0037180802
-
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis
-
Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW, Chung SC, Sung JJ: Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347(26): 2104-2110, 2002
-
(2002)
N Engl J Med
, vol.347
, Issue.26
, pp. 2104-2110
-
-
Chan, F.K.1
Hung, L.C.2
Suen, B.Y.3
Wu, J.C.4
Lee, K.C.5
Leung, V.K.6
Hui, A.J.7
To, K.F.8
Leung, W.K.9
Wong, V.W.10
Chung, S.C.11
Sung, J.J.12
-
114
-
-
0037027050
-
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
-
Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR: COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 360(9339): 1071-1073, 2002
-
(2002)
Lancet
, vol.360
, Issue.9339
, pp. 1071-1073
-
-
Ray, W.A.1
Stein, C.M.2
Daugherty, J.R.3
Hall, K.4
Arbogast, P.G.5
Griffin, M.R.6
-
115
-
-
0035934070
-
Risk of cardiovascular events associated with selective COX-2 inhibitors
-
Mukherjee D, Nissen SE, Topol EJ: Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286(8): 954-959, 2001
-
(2001)
JAMA
, vol.286
, Issue.8
, pp. 954-959
-
-
Mukherjee, D.1
Nissen, S.E.2
Topol, E.J.3
-
116
-
-
0035004747
-
Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth
-
Mann M, Sheng H, Shao J, Williams CS, Pisacane PI, Sliwkowski MX, DuBois RN: Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology 120(7): 1713-1719, 2001
-
(2001)
Gastroenterology
, vol.120
, Issue.7
, pp. 1713-1719
-
-
Mann, M.1
Sheng, H.2
Shao, J.3
Williams, C.S.4
Pisacane, P.I.5
Sliwkowski, M.X.6
DuBois, R.N.7
-
117
-
-
0037311125
-
Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice
-
Yao M, Kargman S, Lam EC, Kelly CR, Zheng Y, Luk P, Kwong E, Evans JF, Wolfe MM: Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res 63(3): 586-592, 2003
-
(2003)
Cancer Res
, vol.63
, Issue.3
, pp. 586-592
-
-
Yao, M.1
Kargman, S.2
Lam, E.C.3
Kelly, C.R.4
Zheng, Y.5
Luk, P.6
Kwong, E.7
Evans, J.F.8
Wolfe, M.M.9
-
118
-
-
0037108880
-
Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11
-
Trifan OC, Durham WF, Salazar VS, Horton J, Levine BD, Zweifel BS, Davis TW, Masferrer JL: Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11. Cancer Res 62(20): 5778-5784, 2002
-
(2002)
Cancer Res
, vol.62
, Issue.20
, pp. 5778-5784
-
-
Trifan, O.C.1
Durham, W.F.2
Salazar, V.S.3
Horton, J.4
Levine, B.D.5
Zweifel, B.S.6
Davis, T.W.7
Masferrer, J.L.8
-
119
-
-
0030070735
-
Phase I trial of sulindac plus 5-fluorouracil and levamisole: Potential adjuvant therapy for colon carcinoma
-
Sinicrope FA, Pazdur R, Levin B: Phase I trial of sulindac plus 5-fluorouracil and levamisole: Potential adjuvant therapy for colon carcinoma. Clin Cancer Res 2(1): 37-41, 1996
-
(1996)
Clin Cancer Res
, vol.2
, Issue.1
, pp. 37-41
-
-
Sinicrope, F.A.1
Pazdur, R.2
Levin, B.3
-
120
-
-
0000539777
-
A phase II trial of celecoxib, irinotecan, 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal cancer
-
Blanke CD, Benson AB, Dragovich T, Lenz H, Haller D, Robles C, Buchbinder A: A phase II trial of celecoxib, irinotecan, 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal cancer. in Proc Am Soc of Clin Onc, 2002
-
(2002)
Proc Am Soc of Clin Onc
-
-
Blanke, C.D.1
Benson, A.B.2
Dragovich, T.3
Lenz, H.4
Haller, D.5
Robles, C.6
Buchbinder, A.7
-
121
-
-
0034162780
-
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor
-
Kishi K, Petersen S, Petersen C, Hunter N, Mason K, Masferrer JL, Tofilon PJ, Milas L: Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res 60(5): 1326-1331, 2000
-
(2000)
Cancer Res
, vol.60
, Issue.5
, pp. 1326-1331
-
-
Kishi, K.1
Petersen, S.2
Petersen, C.3
Hunter, N.4
Mason, K.5
Masferrer, J.L.6
Tofilon, P.J.7
Milas, L.8
|